ALENDRONATE SODIUM TABLET

ALENDRONATE SODIUM TABLET was reported 18833 times

ALENDRONATE SODIUM TABLET is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 ATYPICAL FEMUR FRACTURE 280 0.0992
1 ATYPICAL FRACTURE 54 0.0877
2 GRANULOMA SKIN 55 0.0670
3 PERIPROSTHETIC FRACTURE 24 0.0635
4 RED BLOOD CELL SEDIMENTATION RATE 14 0.0502
5 REVERSIBLE AIRWAYS OBSTRUCTION 24 0.0472
6 BLOOD PARATHYROID HORMONE DECREASED 67 0.0452
7 FRACTURE DISPLACEMENT 19 0.0443
8 TOTAL LUNG CAPACITY ABNORMAL 16 0.0411
9 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 25 0.0374
10 LUPUS VULGARIS 46 0.0365
11 VITAL CAPACITY DECREASED 16 0.0357
12 PULMONARY VASCULITIS 19 0.0353
13 MYCOTIC ALLERGY 29 0.0339
14 RHEUMATIC FEVER 145 0.0325
15 C-REACTIVE PROTEIN 30 0.0324
16 SPIROMETRY ABNORMAL 19 0.0318
17 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 217 0.0303
18 DEEP VEIN THROMBOSIS POSTOPERATIVE 58 0.0290
19 DUODENAL ULCER PERFORATION 212 0.0285
20 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 59 0.0284
21 SWOLLEN JOINT COUNT INCREASED 87 0.0273
22 FACET JOINT SYNDROME 83 0.0255
23 DISLOCATION OF VERTEBRA 57 0.0250
24 RHEUMATOID NODULE 68 0.0247
25 ANTINEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE 18 0.0246
26 MITE ALLERGY 16 0.0244
27 PANNICULITIS 59 0.0244
28 ULNA FRACTURE 23 0.0232
29 RHEUMATOID FACTOR POSITIVE 133 0.0230
30 AMAUROSIS FUGAX 24 0.0223
31 X-RAY ABNORMAL 38 0.0212
32 SPUTUM CULTURE POSITIVE 17 0.0209
33 FRACTURE NONUNION 28 0.0205
34 MUSCLE INJURY 169 0.0204
35 PEMPHIGUS 252 0.0201
36 HELICOBACTER INFECTION 206 0.0200
37 DRUG TOLERANCE DECREASED 55 0.0196
38 C-REACTIVE PROTEIN ABNORMAL 124 0.0193
39 FOLLICULITIS 202 0.0192
40 HAND DEFORMITY 245 0.0187
41 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 118 0.0182
42 JAW OPERATION 16 0.0180
43 BONE DEMINERALISATION 19 0.0179
44 RETINITIS 31 0.0179
45 EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS 36 0.0176
46 EXPOSED BONE IN JAW 38 0.0175
47 DUST ALLERGY 17 0.0173
48 PERIPHERAL VENOUS DISEASE 69 0.0169
49 SERONEGATIVE ARTHRITIS 19 0.0166
50 STRESS FRACTURE 86 0.0159
51 PATHOLOGICAL FRACTURE 79 0.0156
52 ONYCHOMADESIS 63 0.0150
53 BLOOD PRESSURE SYSTOLIC ABNORMAL 37 0.0150
54 BRONCHIAL SECRETION RETENTION 19 0.0149
55 NEURITIS 23 0.0149
56 PERICARDITIS 250 0.0149
57 OSTEONECROSIS OF JAW 366 0.0148
58 RHEUMATOID LUNG 14 0.0147
59 GRIP STRENGTH DECREASED 129 0.0146
60 SYNOVITIS 264 0.0146
61 FINGER DEFORMITY 65 0.0134
62 THORACIC VERTEBRAL FRACTURE 39 0.0132
63 BLOOD PRESSURE DIASTOLIC ABNORMAL 32 0.0126
64 ONYCHOMYCOSIS 55 0.0125
65 ABSCESS JAW 13 0.0125
66 BREAST CANCER STAGE III 79 0.0122
67 ENTHESOPATHY 19 0.0121
68 GLOSSODYNIA 258 0.0115
69 CONJUNCTIVITIS ALLERGIC 17 0.0115
70 BONE EROSION 40 0.0113
71 FEMUR FRACTURE 349 0.0113
72 TENOSYNOVITIS 31 0.0112
73 NEPHROGENIC ANAEMIA 51 0.0110
74 NEOPLASM SKIN 17 0.0109
75 RESPIRATORY SYMPTOM 31 0.0109
76 JOINT RANGE OF MOTION DECREASED 144 0.0107
77 SKIN NECROSIS 55 0.0106
78 OSTEITIS 26 0.0103
79 LIP DRY 93 0.0102
80 FORCED EXPIRATORY VOLUME DECREASED 29 0.0102
81 HYPERCHOLESTEROLAEMIA 98 0.0101
82 LUMBAR VERTEBRAL FRACTURE 46 0.0100
83 SCLERITIS 16 0.0100
84 BURSITIS 121 0.0100
85 WALKING AID USER 65 0.0098
86 WOUND 272 0.0097
87 IRRITABLE BOWEL SYNDROME 206 0.0096
88 TIBIA FRACTURE 45 0.0096
89 REBOUND ACID HYPERSECRETION 29 0.0096
90 HYPERPARATHYROIDISM SECONDARY 24 0.0096
91 OSTEOPOROSIS 391 0.0095
92 WOUND INFECTION 102 0.0093
93 LIVE BIRTH 76 0.0091
94 OSTEOPOROTIC FRACTURE 17 0.0089
95 PRODUCT PACKAGING DIFFICULT TO OPEN 23 0.0088
96 SHOULDER FRACTURE 14 0.0086
97 OSTEOPENIA 129 0.0085
98 IMPAIRED HEALING 277 0.0084
99 LOW TURNOVER OSTEOPATHY 33 0.0083
100 RED BLOOD CELL SEDIMENTATION RATE INCREASED 90 0.0081
101 SYSTEMIC LUPUS ERYTHEMATOSUS 285 0.0080
102 CONTRAINDICATED PRODUCT ADMINISTERED 236 0.0078
103 BLOOD PRESSURE SYSTOLIC INCREASED 151 0.0077
104 HYPERCALCAEMIA 95 0.0077
105 FOOT DEFORMITY 84 0.0076
106 POLYMYALGIA RHEUMATICA 24 0.0075
107 COELIAC DISEASE 74 0.0075
108 BLEPHAROSPASM 47 0.0075
109 LOOSE TOOTH 24 0.0074
110 BACK INJURY 81 0.0074
111 WEIGHT BEARING DIFFICULTY 20 0.0074
112 JAW FRACTURE 16 0.0074
113 URINARY TRACT DISORDER 33 0.0073
114 PELVIC FRACTURE 57 0.0073
115 FIBULA FRACTURE 21 0.0073
116 SPINAL FRACTURE 146 0.0073
117 SPINAL COMPRESSION FRACTURE 60 0.0072
118 FEMORAL NECK FRACTURE 37 0.0072
119 EXOSTOSIS 65 0.0071
120 NAIL DISORDER 62 0.0071
121 WRIST FRACTURE 84 0.0070
122 WOUND COMPLICATION 24 0.0070
123 FIBROMYALGIA 169 0.0069
124 PULMONARY FIBROSIS 133 0.0069
125 HIP ARTHROPLASTY 106 0.0069
126 AUTOIMMUNE DISORDER 66 0.0068
127 PRODUCT LABEL CONFUSION 39 0.0067
128 INFUSION RELATED REACTION 440 0.0066
129 BLOOD IMMUNOGLOBULIN E INCREASED 16 0.0066
130 OBSTRUCTIVE AIRWAYS DISORDER 73 0.0066
131 ARTHROPATHY 354 0.0064
132 OSTEOARTHRITIS 270 0.0064
133 BONE DISORDER 116 0.0064
134 OESOPHAGEAL ULCER 24 0.0062
135 LIVER INJURY 153 0.0062
136 GAIT INABILITY 206 0.0062
137 JOINT DISLOCATION 65 0.0061
138 LOWER LIMB FRACTURE 117 0.0061
139 OBESITY 96 0.0060
140 BASAL CELL CARCINOMA 94 0.0060
141 HUMERUS FRACTURE 29 0.0060
142 PATELLA FRACTURE 14 0.0060
143 LOSS OF EMPLOYMENT 18 0.0060
144 SPONDYLITIS 21 0.0058
145 LOWER RESPIRATORY TRACT INFECTION 259 0.0057
146 PSORIATIC ARTHROPATHY 231 0.0057
147 POLYARTHRITIS 30 0.0057
148 C-REACTIVE PROTEIN INCREASED 206 0.0057
149 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 270 0.0056
150 THERAPEUTIC PRODUCT EFFECT DECREASED 251 0.0056
151 SCIATICA 88 0.0055
152 KNEE ARTHROPLASTY 116 0.0055
153 TYPE 2 DIABETES MELLITUS 183 0.0054
154 BODY HEIGHT DECREASED 58 0.0054
155 BLOOD PRESSURE DIASTOLIC DECREASED 40 0.0054
156 PULMONARY ALVEOLAR HAEMORRHAGE 30 0.0053
157 CUSHINGOID 17 0.0053
158 LUPUS-LIKE SYNDROME 48 0.0053
159 JOINT EFFUSION 36 0.0052
160 CERVICAL VERTEBRAL FRACTURE 18 0.0052
161 CONCOMITANT DISEASE AGGRAVATED 32 0.0052
162 RESPIRATORY RATE INCREASED 46 0.0052
163 CHONDROPATHY 14 0.0052
164 WOUND SECRETION 20 0.0051
165 UPPER-AIRWAY COUGH SYNDROME 42 0.0051
166 BLOOD CHOLESTEROL INCREASED 236 0.0051
167 CREPITATIONS 15 0.0050
168 BLOOD PRESSURE FLUCTUATION 120 0.0050
169 NORMOCHROMIC NORMOCYTIC ANAEMIA 15 0.0050
170 SYNOVIAL CYST 23 0.0050
171 BODY TEMPERATURE DECREASED 49 0.0050
172 CLAVICLE FRACTURE 19 0.0050
173 FOOT FRACTURE 94 0.0050
174 DRUG TOLERANCE 25 0.0049
175 SPINAL FUSION SURGERY 20 0.0049
176 OSTEOMYELITIS 88 0.0049
177 ARTERIOSCLEROSIS CORONARY ARTERY 32 0.0048
178 FULL BLOOD COUNT ABNORMAL 51 0.0048
179 HIP FRACTURE 155 0.0048
180 PRESCRIBED OVERDOSE 93 0.0048
181 IDIOPATHIC PULMONARY FIBROSIS 19 0.0048
182 LIVER FUNCTION TEST INCREASED 103 0.0048
183 INFLAMMATION 246 0.0048
184 BRONCHIECTASIS 32 0.0047
185 BLISTER 266 0.0047
186 BONE LESION 17 0.0047
187 PURULENT DISCHARGE 20 0.0047
188 HEPATIC ENZYME INCREASED 319 0.0047
189 NODULE 61 0.0047
190 RHEUMATOID ARTHRITIS 520 0.0046
191 BLOOD PRESSURE DIASTOLIC INCREASED 21 0.0045
192 OESOPHAGITIS 49 0.0045
193 RIB FRACTURE 92 0.0045
194 SKIN ULCER 115 0.0044
195 SPUTUM DISCOLOURED 42 0.0044
196 FAECAL CALPROTECTIN INCREASED 14 0.0044
197 PULMONARY MASS 65 0.0044
198 MYASTHENIA GRAVIS 35 0.0043
199 STOMATITIS 261 0.0043
200 COMPRESSION FRACTURE 23 0.0043
201 WHEEZING 254 0.0043
202 PNEUMONIA ASPIRATION 107 0.0043
203 MULTIPLE FRACTURES 70 0.0043
204 LUNG TRANSPLANT 15 0.0042
205 ULCER 67 0.0042
206 MOBILITY DECREASED 301 0.0042
207 DRUG-INDUCED LIVER INJURY 130 0.0041
208 POLYP 27 0.0041
209 DRUG ERUPTION 73 0.0041
210 OSTEONECROSIS 135 0.0041
211 PEMPHIGOID 31 0.0041
212 SPINAL OSTEOARTHRITIS 36 0.0041
213 CHRONIC KIDNEY DISEASE 311 0.0041
214 DISCOMFORT 249 0.0041
215 LUNG DISORDER 199 0.0041
216 BONE DENSITY DECREASED 127 0.0040
217 ANKLE FRACTURE 62 0.0040
218 ANTINUCLEAR ANTIBODY POSITIVE 13 0.0040
219 HEPATIC CIRRHOSIS 75 0.0040
220 PRODUCTIVE COUGH 190 0.0040
221 POOR VENOUS ACCESS 41 0.0040
222 EOSINOPHIL COUNT INCREASED 33 0.0040
223 ABDOMINAL HERNIA 18 0.0039
224 ILL-DEFINED DISORDER 238 0.0039
225 TOOTH FRACTURE 43 0.0039
226 CONTUSION 375 0.0039
227 PERIPHERAL SWELLING 600 0.0039
228 JOINT SWELLING 468 0.0039
229 GROIN PAIN 34 0.0039
230 NEUROLOGICAL SYMPTOM 22 0.0038
231 ULCER HAEMORRHAGE 26 0.0038
232 HAEMORRHAGIC STROKE 30 0.0038
233 OCULAR DISCOMFORT 43 0.0038
234 MYOPATHY 33 0.0038
235 SWELLING 357 0.0038
236 INTERVERTEBRAL DISC DEGENERATION 35 0.0038
237 MUSCULOSKELETAL PAIN 198 0.0038
238 CLOSTRIDIUM DIFFICILE COLITIS 40 0.0038
239 EAR PAIN 73 0.0038
240 BONE DENSITY ABNORMAL 14 0.0037
241 CHRONIC SINUSITIS 14 0.0037
242 MUSCULOSKELETAL STIFFNESS 325 0.0037
243 PRESCRIBED UNDERDOSE 74 0.0037
244 TASTE DISORDER 75 0.0037
245 VITAMIN D DEFICIENCY 36 0.0037
246 UPPER GASTROINTESTINAL HAEMORRHAGE 62 0.0037
247 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 20 0.0037
248 IMMOBILE 16 0.0037
249 GASTRIC INFECTION 14 0.0037
250 JOINT STIFFNESS 96 0.0037
251 FRACTURE 69 0.0036
252 NIGHT SWEATS 117 0.0036
253 FALL 1200 0.0036
254 VIRAL UPPER RESPIRATORY TRACT INFECTION 17 0.0036
255 MULTIPLE ALLERGIES 28 0.0036
256 ANAL INCONTINENCE 32 0.0036
257 HAND FRACTURE 25 0.0035
258 BLADDER DISORDER 35 0.0035
259 SKIN LACERATION 38 0.0035
260 VARICOSE VEIN 18 0.0035
261 MUSCLE STRAIN 30 0.0035
262 NASAL POLYPS 17 0.0034
263 LIGAMENT SPRAIN 34 0.0034
264 SENSITIVITY TO WEATHER CHANGE 18 0.0034
265 HAEMORRHAGIC ANAEMIA 15 0.0034
266 GASTROOESOPHAGEAL REFLUX DISEASE 274 0.0034
267 ARTERIOSCLEROSIS 32 0.0034
268 END STAGE RENAL DISEASE 62 0.0034
269 SKIN INFECTION 38 0.0034
270 OXYGEN SATURATION DECREASED 190 0.0034
271 LIVER DISORDER 149 0.0034
272 TENDONITIS 52 0.0034
273 DRUG INTOLERANCE 324 0.0034
274 BONE LOSS 50 0.0033
275 NECK PAIN 185 0.0033
276 HEART RATE DECREASED 116 0.0033
277 INTENTIONAL PRODUCT USE ISSUE 286 0.0033
278 GASTROINTESTINAL DISORDER 292 0.0033
279 ARTHRITIS 256 0.0033
280 BLOOD CHOLESTEROL ABNORMAL 15 0.0032
281 ARTHRITIS INFECTIVE 15 0.0032
282 CONGENITAL ANOMALY 25 0.0032
283 CATARACT 192 0.0032
284 TENDON DISORDER 21 0.0032
285 MUSCULAR WEAKNESS 366 0.0032
286 LIMB INJURY 87 0.0032
287 DELIRIUM 111 0.0032
288 PULMONARY FUNCTION TEST DECREASED 14 0.0032
289 BLOOD ALBUMIN DECREASED 25 0.0031
290 RENAL CYST 25 0.0031
291 JOINT INJURY 67 0.0031
292 SINUSITIS 319 0.0031
293 BONE PAIN 180 0.0031
294 TENDERNESS 32 0.0031
295 DYSPNOEA EXERTIONAL 115 0.0031
296 TONGUE DISORDER 22 0.0030
297 IRON DEFICIENCY ANAEMIA 28 0.0030
298 RESPIRATORY TRACT INFECTION 79 0.0030
299 ORGANISING PNEUMONIA 15 0.0030
300 ABDOMINAL DISCOMFORT 507 0.0030
301 ADVERSE REACTION 40 0.0030
302 UPPER LIMB FRACTURE 60 0.0030
303 BREAST CANCER STAGE II 25 0.0030
304 ARTHRALGIA 1249 0.0030
305 DEFAECATION URGENCY 21 0.0030
306 FLANK PAIN 28 0.0030
307 SPINAL PAIN 35 0.0030
308 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 155 0.0030
309 EAR INFECTION 79 0.0030
310 TOOTH DISORDER 66 0.0030
311 PAIN IN JAW 84 0.0030
312 SLEEP DISORDER 209 0.0030
313 POST PROCEDURAL INFECTION 24 0.0029
314 TOOTH ABSCESS 30 0.0029
315 HEAD DISCOMFORT 52 0.0029
316 HAIR DISORDER 24 0.0029
317 ECONOMIC PROBLEM 44 0.0029
318 MOVEMENT DISORDER 92 0.0029
319 SPINAL DISORDER 27 0.0028
320 HAEMATEMESIS 72 0.0028
321 VASCULITIS 33 0.0028
322 PNEUMONIA BACTERIAL 26 0.0028
323 RESPIRATORY TRACT CONGESTION 45 0.0028
324 FOOT OPERATION 14 0.0028
325 INFECTION 409 0.0028
326 ASPHYXIA 23 0.0028
327 PERONEAL NERVE PALSY 16 0.0028
328 ADRENAL INSUFFICIENCY 34 0.0028
329 NOCTURIA 34 0.0028
330 BLOOD IRON DECREASED 33 0.0028
331 SINUS DISORDER 55 0.0028
332 HIP SURGERY 15 0.0028
333 LOCALISED INFECTION 67 0.0028
334 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 47 0.0028
335 GINGIVAL PAIN 22 0.0028
336 HYPOKINESIA 40 0.0028
337 ASTHMA 311 0.0027
338 IMMUNODEFICIENCY 41 0.0027
339 JAW DISORDER 15 0.0027
340 HEPATIC STEATOSIS 51 0.0027
341 TOOTH EXTRACTION 34 0.0027
342 OEDEMA 148 0.0027
343 HIATUS HERNIA 35 0.0027
344 DYSPEPSIA 265 0.0027
345 NASOPHARYNGITIS 496 0.0027
346 INJURY 189 0.0027
347 PAIN IN EXTREMITY 792 0.0027
348 CARDIAC PACEMAKER INSERTION 16 0.0027
349 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 46 0.0027
350 BRONCHITIS 198 0.0027
351 DYSSTASIA 78 0.0027
352 ANHEDONIA 70 0.0027
353 ALOPECIA 522 0.0027
354 EYE INFECTION 30 0.0027
355 SQUAMOUS CELL CARCINOMA 25 0.0027
356 GENERAL PHYSICAL HEALTH DETERIORATION 307 0.0027
357 BREATH SOUNDS ABNORMAL 13 0.0026
358 GASTROINTESTINAL PAIN 29 0.0026
359 DRY MOUTH 212 0.0026
360 CYSTITIS 83 0.0026
361 GASTROENTERITIS 38 0.0026
362 GAIT DISTURBANCE 498 0.0026
363 NERVE COMPRESSION 24 0.0026
364 SPINAL OPERATION 32 0.0026
365 HERPES ZOSTER 149 0.0026
366 FREQUENT BOWEL MOVEMENTS 70 0.0026
367 THERAPY NON-RESPONDER 116 0.0026
368 HEPATITIS 66 0.0026
369 LUNG INFECTION 40 0.0026
370 NEPHROPATHY 24 0.0026
371 ROTATOR CUFF SYNDROME 33 0.0026
372 RIGHT VENTRICULAR FAILURE 18 0.0026
373 MUSCULOSKELETAL DISCOMFORT 44 0.0026
374 NONSPECIFIC REACTION 14 0.0025
375 PSYCHOLOGICAL TRAUMA 22 0.0025
376 CONFUSIONAL STATE 411 0.0025
377 INTESTINAL ISCHAEMIA 14 0.0025
378 DISABILITY 50 0.0025
379 PNEUMONIA 813 0.0025
380 ABNORMAL LOSS OF WEIGHT 17 0.0025
381 UROSEPSIS 23 0.0025
382 SQUAMOUS CELL CARCINOMA OF SKIN 15 0.0025
383 SECRETION DISCHARGE 31 0.0025
384 URINARY TRACT INFECTION 422 0.0025
385 BLOOD PRESSURE INCREASED 377 0.0025
386 ROAD TRAFFIC ACCIDENT 103 0.0025
387 FOOD ALLERGY 19 0.0025
388 LOW DENSITY LIPOPROTEIN INCREASED 19 0.0025
389 LARGE INTESTINE POLYP 17 0.0025
390 BALANCE DISORDER 212 0.0025
391 HEART RATE IRREGULAR 55 0.0024
392 CARPAL TUNNEL SYNDROME 34 0.0024
393 RENAL INJURY 72 0.0024
394 LIMB DISCOMFORT 75 0.0024
395 GENERALISED OEDEMA 30 0.0024
396 SCOLIOSIS 15 0.0024
397 TOOTH LOSS 50 0.0024
398 BACK DISORDER 39 0.0024
399 HYPOVOLAEMIA 14 0.0024
400 CELLULITIS 120 0.0024
401 INTERVERTEBRAL DISC PROTRUSION 52 0.0024
402 WHITE BLOOD CELL COUNT INCREASED 91 0.0024
403 COLITIS ISCHAEMIC 16 0.0024
404 INFLUENZA 264 0.0024
405 HAEMOPTYSIS 66 0.0024
406 RASH PRURITIC 128 0.0024
407 CATARACT OPERATION 14 0.0024
408 DEAFNESS UNILATERAL 13 0.0024
409 TREATMENT FAILURE 195 0.0024
410 AMNESIA 153 0.0023
411 DENTAL CARIES 26 0.0023
412 VITAMIN D DECREASED 20 0.0023
413 HYPERTENSION 495 0.0023
414 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 166 0.0023
415 LYMPHOMA 36 0.0023
416 INTENTIONAL UNDERDOSE 17 0.0023
417 ORAL PAIN 52 0.0023
418 HYPOAESTHESIA 347 0.0023
419 GASTRIC ULCER 44 0.0023
420 CARDIAC MURMUR 20 0.0023
421 BLOOD COUNT ABNORMAL 35 0.0023
422 BODY TEMPERATURE INCREASED 47 0.0023
423 HYPOPHOSPHATAEMIA 17 0.0023
424 WEIGHT FLUCTUATION 24 0.0023
425 ORAL CANDIDIASIS 30 0.0023
426 PULMONARY ARTERIAL HYPERTENSION 33 0.0023
427 HYPOPHAGIA 58 0.0023
428 IMMUNOSUPPRESSION 20 0.0023
429 TOOTHACHE 41 0.0023
430 PULMONARY TOXICITY 16 0.0023
431 HYPERLIPIDAEMIA 27 0.0023
432 MUSCULOSKELETAL DISORDER 43 0.0023
433 INTERSTITIAL LUNG DISEASE 109 0.0022
434 HAIR COLOUR CHANGES 28 0.0022
435 HYPOXIA 79 0.0022
436 THERAPY CESSATION 115 0.0022
437 HYPERSENSITIVITY 414 0.0022
438 MASS 31 0.0022
439 BLOOD TEST ABNORMAL 31 0.0022
440 FAECES SOFT 16 0.0022
441 RHINORRHOEA 142 0.0022
442 TRANSFUSION 23 0.0022
443 URINARY INCONTINENCE 65 0.0022
444 BRONCHOPULMONARY ASPERGILLOSIS 17 0.0022
445 TUBULOINTERSTITIAL NEPHRITIS 41 0.0022
446 EMPHYSEMA 22 0.0022
447 ABDOMINAL PAIN UPPER 449 0.0022
448 PHOTOPHOBIA 41 0.0022
449 ATELECTASIS 21 0.0022
450 EYE HAEMORRHAGE 29 0.0022
451 RESPIRATORY DISORDER 65 0.0022
452 HEART RATE INCREASED 215 0.0022
453 ASPARTATE AMINOTRANSFERASE INCREASED 115 0.0022
454 IMPAIRED QUALITY OF LIFE 31 0.0022
455 SLEEP APNOEA SYNDROME 41 0.0021
456 CONDITION AGGRAVATED 650 0.0021
457 BLOOD CALCIUM DECREASED 24 0.0021
458 BACK PAIN 495 0.0021
459 HYPOTHYROIDISM 68 0.0021
460 BLOOD POTASSIUM DECREASED 64 0.0021
461 LACERATION 20 0.0021
462 MEMORY IMPAIRMENT 292 0.0021
463 COUGH 595 0.0021
464 SENSORY DISTURBANCE 34 0.0021
465 NEPHROLITHIASIS 97 0.0021
466 SMALL INTESTINAL OBSTRUCTION 26 0.0021
467 DIVERTICULUM 15 0.0021
468 BLOOD URINE PRESENT 40 0.0021
469 WEIGHT INCREASED 471 0.0021
470 FEAR OF INJECTION 15 0.0021
471 CARDIAC FAILURE ACUTE 14 0.0021
472 HAEMORRHOIDS 41 0.0021
473 MATERNAL EXPOSURE DURING PREGNANCY 187 0.0021
474 MACULAR DEGENERATION 25 0.0021
475 HAIR TEXTURE ABNORMAL 28 0.0021
476 GASTRITIS 55 0.0021
477 MOUTH ULCERATION 44 0.0021
478 BLOOD MAGNESIUM DECREASED 18 0.0021
479 PARAESTHESIA ORAL 30 0.0021
480 PYELONEPHRITIS 18 0.0021
481 PLATELET COUNT INCREASED 27 0.0021
482 MADAROSIS 24 0.0021
483 APHTHOUS ULCER 16 0.0021
484 HYPONATRAEMIA 116 0.0021
485 PAIN 1262 0.0021
486 BLOOD CALCIUM INCREASED 18 0.0021
487 ORAL DISORDER 15 0.0020
488 SKIN CANCER 44 0.0020
489 DECREASED APPETITE 474 0.0020
490 DIPLOPIA 53 0.0020
491 FULL BLOOD COUNT DECREASED 41 0.0020
492 ONYCHOCLASIS 14 0.0020
493 FAECES DISCOLOURED 44 0.0020
494 HEAD INJURY 64 0.0020
495 ASTHENIA 759 0.0020
496 FACIAL PAIN 18 0.0020
497 LARGE INTESTINE PERFORATION 14 0.0020
498 UPPER RESPIRATORY TRACT INFECTION 93 0.0020
499 ACUTE KIDNEY INJURY 308 0.0020
500 THYROID DISORDER 31 0.0020
501 MUSCULOSKELETAL CHEST PAIN 31 0.0020
502 SEPSIS 223 0.0020
503 OROPHARYNGEAL PAIN 185 0.0020
504 BLOOD DISORDER 16 0.0020
505 COMA 95 0.0020
506 GASTRIC DISORDER 68 0.0020
507 ACUTE RESPIRATORY FAILURE 38 0.0020
508 HAEMOGLOBIN DECREASED 202 0.0020
509 WEIGHT DECREASED 549 0.0020
510 BLOOD SODIUM DECREASED 37 0.0020
511 EPILEPSY 60 0.0020
512 EAR DISCOMFORT 20 0.0019
513 TENDON RUPTURE 24 0.0019
514 ALTERED STATE OF CONSCIOUSNESS 42 0.0019
515 RENAL TUBULAR NECROSIS 19 0.0019
516 EATING DISORDER 41 0.0019
517 VIRAL INFECTION 64 0.0019
518 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 17 0.0019
519 ALANINE AMINOTRANSFERASE INCREASED 118 0.0019
520 GASTROINTESTINAL INFLAMMATION 15 0.0019
521 NEOPLASM 22 0.0019
522 DYSPNOEA 1082 0.0019
523 CONSTIPATION 416 0.0019
524 PRODUCT DOSE OMISSION 124 0.0019
525 TOOTH INFECTION 25 0.0019
526 SKIN LESION 52 0.0019
527 LOWER GASTROINTESTINAL HAEMORRHAGE 14 0.0019
528 INCONTINENCE 20 0.0019
529 PRESYNCOPE 46 0.0019
530 MEDICATION ERROR 105 0.0019
531 PRODUCT ADMINISTRATION ERROR 38 0.0019
532 DIVERTICULITIS 52 0.0019
533 FISTULA 21 0.0019
534 APHONIA 26 0.0019
535 RECTAL HAEMORRHAGE 80 0.0019
536 INITIAL INSOMNIA 19 0.0018
537 HYPOCALCAEMIA 35 0.0018
538 ABDOMINAL DISTENSION 193 0.0018
539 DIARRHOEA 1191 0.0018
540 HAEMATURIA 63 0.0018
541 RESPIRATORY SYNCYTIAL VIRUS INFECTION 16 0.0018
542 RENAL FAILURE 244 0.0018
543 KIDNEY INFECTION 36 0.0018
544 ACIDOSIS 14 0.0018
545 GASTROINTESTINAL HAEMORRHAGE 153 0.0018
546 URINE OUTPUT DECREASED 16 0.0018
547 GASTROENTERITIS VIRAL 33 0.0018
548 FEEDING DISORDER 37 0.0018
549 INTERNATIONAL NORMALISED RATIO INCREASED 52 0.0018
550 FATIGUE 1419 0.0018
551 RED BLOOD CELL COUNT DECREASED 52 0.0018
552 GLAUCOMA 35 0.0018
553 OEDEMA PERIPHERAL 221 0.0018
554 DYSPHONIA 106 0.0018
555 HYPOACUSIS 78 0.0018
556 MYALGIA 307 0.0018
557 ORAL DISCOMFORT 25 0.0018
558 FEELING COLD 50 0.0018
559 MUSCLE SPASTICITY 22 0.0018
560 BLOOD POTASSIUM INCREASED 29 0.0018
561 MYOSITIS 16 0.0018
562 SINUS CONGESTION 24 0.0018
563 CHROMATURIA 40 0.0018
564 DRY THROAT 18 0.0018
565 ILEUS 22 0.0018
566 NASAL CONGESTION 104 0.0018
567 HAEMATOCRIT DECREASED 35 0.0018
568 ABDOMINAL PAIN 410 0.0018
569 BLOOD PRESSURE ABNORMAL 35 0.0018
570 PSEUDOMONAS INFECTION 15 0.0017
571 SUBDURAL HAEMATOMA 25 0.0017
572 PULMONARY THROMBOSIS 19 0.0017
573 CLOSTRIDIUM DIFFICILE INFECTION 38 0.0017
574 EYE PAIN 98 0.0017
575 MUSCLE SPASMS 318 0.0017
576 KNEE OPERATION 17 0.0017
577 ATRIAL FIBRILLATION 168 0.0017
578 INTESTINAL OBSTRUCTION 65 0.0017
579 CHILLS 202 0.0017
580 DRY EYE 86 0.0017
581 HOSPICE CARE 17 0.0017
582 THERAPY INTERRUPTED 123 0.0017
583 INSOMNIA 458 0.0017
584 PRODUCT USE ISSUE 322 0.0017
585 DIARRHOEA HAEMORRHAGIC 16 0.0017
586 GLOMERULAR FILTRATION RATE DECREASED 21 0.0017
587 HEPATOTOXICITY 38 0.0017
588 HERNIA 33 0.0017
589 HALLUCINATION, VISUAL 36 0.0017
590 BLOOD ALKALINE PHOSPHATASE INCREASED 42 0.0017
591 CHEST PAIN 313 0.0017
592 DEVICE RELATED INFECTION 26 0.0017
593 LACRIMATION INCREASED 51 0.0017
594 INTENTIONAL DOSE OMISSION 48 0.0017
595 CHOLECYSTITIS 20 0.0017
596 DRUG LEVEL DECREASED 17 0.0017
597 SENSATION OF FOREIGN BODY 14 0.0017
598 MIGRAINE 158 0.0017
599 VISUAL IMPAIRMENT 205 0.0017
600 HYPOMAGNESAEMIA 23 0.0017
601 MALAISE 724 0.0016
602 PRODUCT USE COMPLAINT 26 0.0016
603 DIZZINESS 821 0.0016
604 RASH 715 0.0016
605 QUALITY OF LIFE DECREASED 22 0.0016
606 MELAENA 36 0.0016
607 SEASONAL ALLERGY 23 0.0016
608 PRODUCT DOSE OMISSION IN ERROR 46 0.0016
609 CARDIOMYOPATHY 24 0.0016
610 NERVE INJURY 18 0.0016
611 PRODUCT DISTRIBUTION ISSUE 15 0.0016
612 COLITIS ULCERATIVE 72 0.0016
613 BACTERIAL INFECTION 30 0.0016
614 MIDDLE INSOMNIA 30 0.0016
615 DECUBITUS ULCER 13 0.0016
616 BLINDNESS 65 0.0016
617 PNEUMOCYSTIS JIROVECII PNEUMONIA 16 0.0016
618 ANKYLOSING SPONDYLITIS 21 0.0016
619 DYSPHAGIA 151 0.0016
620 SARS-COV-2 TEST POSITIVE 21 0.0016
621 PYREXIA 548 0.0016
622 POLLAKIURIA 66 0.0016
623 STAPHYLOCOCCAL INFECTION 52 0.0016
624 DEPRESSION 358 0.0016
625 FLUID RETENTION 80 0.0016
626 EYE INFLAMMATION 15 0.0016
627 MOTOR DYSFUNCTION 16 0.0016
628 ABSCESS 25 0.0016
629 HALLUCINATION 118 0.0016
630 CARDIAC FAILURE 125 0.0016
631 PRURITUS 598 0.0016
632 CHOLELITHIASIS 51 0.0016
633 ASPIRATION 17 0.0016
634 PREGNANCY 31 0.0015
635 LOCAL SWELLING 27 0.0015
636 URTICARIA 259 0.0015
637 HEADACHE 965 0.0015
638 ORAL HERPES 30 0.0015
639 THERAPEUTIC RESPONSE DECREASED 93 0.0015
640 CYST 19 0.0015
641 SPEECH DISORDER 80 0.0015
642 THERAPY CHANGE 15 0.0015
643 DRUG DOSE OMISSION 252 0.0015
644 NEURALGIA 37 0.0015
645 BEDRIDDEN 20 0.0015
646 INCREASED TENDENCY TO BRUISE 14 0.0015
647 PANCYTOPENIA 85 0.0015
648 SCRATCH 16 0.0015
649 BACTERAEMIA 18 0.0015
650 HYPOKALAEMIA 70 0.0015
651 INTESTINAL PERFORATION 17 0.0015
652 MENTAL STATUS CHANGES 42 0.0015
653 CONJUNCTIVITIS 28 0.0015
654 BLOOD PRESSURE DECREASED 100 0.0015
655 REBOUND EFFECT 17 0.0015
656 TINNITUS 69 0.0015
657 DEHYDRATION 200 0.0015
658 ANXIETY 426 0.0015
659 EXPOSURE DURING PREGNANCY 93 0.0015
660 MICTURITION URGENCY 17 0.0015
661 PULMONARY HYPERTENSION 31 0.0015
662 DECREASED ACTIVITY 16 0.0015
663 INJECTION SITE REACTION 102 0.0015
664 SNEEZING 33 0.0015
665 SOMNOLENCE 296 0.0015
666 PARAESTHESIA 231 0.0015
667 HAEMATOCHEZIA 81 0.0015
668 IMPAIRED GASTRIC EMPTYING 20 0.0015
669 NEUTROPHIL COUNT INCREASED 15 0.0015
670 PLEURAL EFFUSION 89 0.0015
671 LABORATORY TEST ABNORMAL 43 0.0015
672 NAUSEA 1148 0.0014
673 JAUNDICE 39 0.0014
674 DEEP VEIN THROMBOSIS 94 0.0014
675 PRODUCT DOSE OMISSION ISSUE 425 0.0014
676 GAMMA-GLUTAMYLTRANSFERASE INCREASED 32 0.0014
677 IMMUNE SYSTEM DISORDER 19 0.0014
678 PULMONARY CONGESTION 19 0.0014
679 SWOLLEN TONGUE 45 0.0014
680 COVID-19 PNEUMONIA 17 0.0014
681 LEUKOCYTOSIS 26 0.0014
682 PHARYNGEAL SWELLING 14 0.0014
683 MALNUTRITION 16 0.0014
684 BURNING SENSATION 100 0.0014
685 CANDIDA INFECTION 24 0.0014
686 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 256 0.0014
687 SYNCOPE 142 0.0014
688 COVID-19 247 0.0014
689 IMPAIRED DRIVING ABILITY 16 0.0014
690 CHOLECYSTECTOMY 16 0.0014
691 INTERNAL HAEMORRHAGE 16 0.0014
692 NERVOUSNESS 73 0.0014
693 OFF LABEL USE 1222 0.0014
694 DEMENTIA 39 0.0014
695 ASCITES 41 0.0014
696 BLOOD CREATININE INCREASED 91 0.0014
697 RENAL IMPAIRMENT 117 0.0014
698 GINGIVAL BLEEDING 19 0.0014
699 DEFORMITY 13 0.0014
700 VOMITING 651 0.0014
701 SEPTIC SHOCK 60 0.0014
702 DEAFNESS 36 0.0014
703 RENAL DISORDER 64 0.0014
704 RESPIRATORY FAILURE 100 0.0014
705 PHARYNGITIS 17 0.0014
706 SWELLING FACE 89 0.0014
707 SURGERY 80 0.0014
708 PULMONARY OEDEMA 61 0.0014
709 RETCHING 29 0.0014
710 THROAT IRRITATION 61 0.0014
711 DYSURIA 50 0.0014
712 MUSCLE TIGHTNESS 22 0.0014
713 LYMPHOCYTE COUNT DECREASED 24 0.0014
714 SKELETAL INJURY 14 0.0014
715 DISEASE RECURRENCE 64 0.0013
716 THROMBOSIS 108 0.0013
717 HEPATIC FUNCTION ABNORMAL 50 0.0013
718 DIABETES MELLITUS 102 0.0013
719 EYE IRRITATION 77 0.0013
720 GOUT 24 0.0013
721 TREATMENT NONCOMPLIANCE 73 0.0013
722 TRANSIENT ISCHAEMIC ATTACK 45 0.0013
723 HYPOAESTHESIA ORAL 20 0.0013
724 MITRAL VALVE INCOMPETENCE 15 0.0013
725 AGEUSIA 33 0.0013
726 CARDIAC FAILURE CONGESTIVE 106 0.0013
727 MYOCARDIAL ISCHAEMIA 15 0.0013
728 HYPERKALAEMIA 46 0.0013
729 ILLNESS 135 0.0013
730 WHITE BLOOD CELL COUNT DECREASED 142 0.0013
731 EYE DISORDER 43 0.0013
732 FLUID OVERLOAD 19 0.0013
733 FEELING HOT 80 0.0013
734 ADVERSE EVENT 120 0.0013
735 POOR QUALITY SLEEP 28 0.0013
736 ELECTROLYTE IMBALANCE 15 0.0013
737 VISION BLURRED 176 0.0013
738 TREMOR 212 0.0013
739 BLINDNESS UNILATERAL 18 0.0013
740 DERMATITIS ALLERGIC 16 0.0013
741 MALIGNANT MELANOMA 17 0.0013
742 DRUG LEVEL INCREASED 21 0.0013
743 THERAPEUTIC RESPONSE SHORTENED 42 0.0013
744 PARALYSIS 18 0.0013
745 EPISTAXIS 94 0.0013
746 UVEITIS 17 0.0013
747 NEPHROPATHY TOXIC 14 0.0012
748 ADVERSE DRUG REACTION 112 0.0012
749 DERMATITIS 26 0.0012
750 INFLUENZA LIKE ILLNESS 102 0.0012
751 PRODUCT USE IN UNAPPROVED INDICATION 307 0.0012
752 PLATELET COUNT DECREASED 132 0.0012
753 ANAEMIA 236 0.0012
754 HYPOTENSION 248 0.0012
755 FLATULENCE 70 0.0012
756 CHEST DISCOMFORT 126 0.0012
757 CHOKING 24 0.0012
758 TACHYCARDIA 109 0.0012
759 COLITIS 46 0.0012
760 PERICARDIAL EFFUSION 28 0.0012
761 PULMONARY EMBOLISM 115 0.0012
762 FEELING JITTERY 23 0.0012
763 LYMPHOPENIA 17 0.0012
764 UNRESPONSIVE TO STIMULI 31 0.0012
765 INJECTION SITE DISCOLOURATION 15 0.0012
766 POST PROCEDURAL COMPLICATION 23 0.0012
767 HOSPITALISATION 184 0.0012
768 ERYTHEMA 246 0.0012
769 HAEMATOMA 31 0.0012
770 BLOOD UREA INCREASED 20 0.0012
771 UNDERDOSE 87 0.0012
772 ERUCTATION 23 0.0012
773 HYPERSOMNIA 34 0.0012
774 MUSCLE ATROPHY 15 0.0012
775 DEVICE FAILURE 18 0.0012
776 ATAXIA 14 0.0012
777 PNEUMONITIS 32 0.0012
778 HYPERTHYROIDISM 17 0.0012
779 FUNGAL INFECTION 39 0.0012
780 URINARY RETENTION 39 0.0012
781 PERIPHERAL COLDNESS 16 0.0012
782 VERTIGO 71 0.0012
783 PROCEDURAL PAIN 32 0.0012
784 THROAT TIGHTNESS 31 0.0011
785 CYTOPENIA 14 0.0011
786 HOT FLUSH 86 0.0011
787 COAGULOPATHY 19 0.0011
788 SKIN DISORDER 38 0.0011
789 CARDIAC DISORDER 106 0.0011
790 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 29 0.0011
791 BRONCHOSPASM 16 0.0011
792 NEUROPATHY PERIPHERAL 105 0.0011
793 PELVIC PAIN 20 0.0011
794 RESTLESS LEGS SYNDROME 20 0.0011
795 BRADYCARDIA 58 0.0011
796 APHASIA 33 0.0011
797 ACCIDENT 13 0.0011
798 LIP SWELLING 36 0.0011
799 LOSS OF CONSCIOUSNESS 138 0.0011
800 OCULAR HYPERAEMIA 51 0.0011
801 HAEMORRHAGE INTRACRANIAL 16 0.0011
802 CEREBRAL INFARCTION 26 0.0011
803 THIRST 19 0.0011
804 DYSGEUSIA 79 0.0011
805 DRUG INTERACTION 168 0.0011
806 SCAR 18 0.0011
807 INSURANCE ISSUE 16 0.0010
808 LUNG NEOPLASM MALIGNANT 43 0.0010
809 SKIN DISCOLOURATION 48 0.0010
810 PANIC ATTACK 38 0.0010
811 EMOTIONAL DISTRESS 126 0.0010
812 BLOOD BILIRUBIN INCREASED 28 0.0010
813 CEREBRAL HAEMORRHAGE 37 0.0010
814 DYSKINESIA 42 0.0010
815 LIVER FUNCTION TEST ABNORMAL 30 0.0010
816 DELUSION 16 0.0010
817 RASH MACULAR 36 0.0010
818 LETHARGY 59 0.0010
819 CORONARY ARTERY OCCLUSION 14 0.0010
820 CYANOSIS 16 0.0010
821 INCORRECT PRODUCT ADMINISTRATION DURATION 22 0.0010
822 DISORIENTATION 40 0.0010
823 GALLBLADDER DISORDER 18 0.0010
824 HEMIPARESIS 17 0.0010
825 CEREBROVASCULAR ACCIDENT 170 0.0010
826 DRUG INEFFECTIVE 1321 0.0010
827 HEPATIC FAILURE 30 0.0010
828 SKIN REACTION 14 0.0010
829 IMPAIRED WORK ABILITY 21 0.0010
830 EYE PRURITUS 33 0.0010
831 RASH PAPULAR 22 0.0010
832 ORTHOSTATIC HYPOTENSION 17 0.0010
833 METASTASES TO BONE 16 0.0010
834 ARRHYTHMIA 46 0.0010
835 PRURITUS GENERALISED 21 0.0010
836 VENTRICULAR TACHYCARDIA 16 0.0010
837 METASTASES TO LIVER 17 0.0010
838 COLD SWEAT 17 0.0010
839 COGNITIVE DISORDER 45 0.0010
840 DYSARTHRIA 36 0.0010
841 PALLOR 26 0.0010
842 MUCOSAL INFLAMMATION 25 0.0010
843 MULTIPLE ORGAN DYSFUNCTION SYNDROME 27 0.0010
844 ABDOMINAL PAIN LOWER 24 0.0009
845 FEELING ABNORMAL 227 0.0009
846 PSORIASIS 123 0.0009
847 MULTIPLE SCLEROSIS 45 0.0009
848 VISUAL ACUITY REDUCED 31 0.0009
849 COORDINATION ABNORMAL 13 0.0009
850 ABASIA 23 0.0009
851 DEPRESSED MOOD 49 0.0009
852 HYPERHIDROSIS 119 0.0009
853 PRODUCT AVAILABILITY ISSUE 21 0.0009
854 BLOOD GLUCOSE ABNORMAL 17 0.0009
855 DIABETIC KETOACIDOSIS 22 0.0009
856 SEIZURE 105 0.0009
857 PHOTOSENSITIVITY REACTION 15 0.0009
858 RESPIRATORY DISTRESS 25 0.0009
859 INTENTIONAL PRODUCT MISUSE 79 0.0009
860 RASH MACULO-PAPULAR 20 0.0009
861 NEOPLASM MALIGNANT 60 0.0009
862 ACUTE MYELOID LEUKAEMIA 14 0.0009
863 PALPITATIONS 105 0.0009
864 BRAIN FOG 14 0.0009
865 PRODUCT PHYSICAL ISSUE 18 0.0009
866 ANGIOEDEMA 39 0.0009
867 HAEMORRHAGE 92 0.0009
868 DRUG ADMINISTRATION ERROR 27 0.0009
869 THERAPEUTIC RESPONSE UNEXPECTED 39 0.0009
870 UNEVALUABLE EVENT 65 0.0009
871 NEUTROPHIL COUNT DECREASED 35 0.0009
872 RASH ERYTHEMATOUS 41 0.0009
873 DRUG EFFECT INCOMPLETE 31 0.0009
874 INJECTION SITE BRUISING 68 0.0009
875 PANCREATITIS 45 0.0009
876 MANIA 14 0.0009
877 PANCREATITIS ACUTE 19 0.0008
878 HYPOGLYCAEMIA 41 0.0008
879 FEBRILE NEUTROPENIA 56 0.0008
880 CYTOMEGALOVIRUS INFECTION 14 0.0008
881 INJECTION SITE PRURITUS 56 0.0008
882 DISEASE PROGRESSION 98 0.0008
883 FLUSHING 84 0.0008
884 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 45 0.0008
885 LYMPHADENOPATHY 29 0.0008
886 MULTIPLE SCLEROSIS RELAPSE 56 0.0008
887 ANGINA PECTORIS 23 0.0008
888 PRODUCT PRESCRIBING ERROR 19 0.0008
889 ACCIDENTAL OVERDOSE 29 0.0008
890 GLYCOSYLATED HAEMOGLOBIN INCREASED 20 0.0008
891 ACUTE RESPIRATORY DISTRESS SYNDROME 14 0.0008
892 CARDIO-RESPIRATORY ARREST 33 0.0008
893 PROTEINURIA 15 0.0008
894 PRODUCT QUALITY ISSUE 107 0.0008
895 INCREASED APPETITE 15 0.0008
896 DEPRESSED LEVEL OF CONSCIOUSNESS 31 0.0008
897 HYPERGLYCAEMIA 28 0.0008
898 EXTRA DOSE ADMINISTERED 31 0.0008
899 RESPIRATORY ARREST 21 0.0008
900 ACTIVITIES OF DAILY LIVING IMPAIRED 15 0.0008
901 DEATH 650 0.0008
902 INJECTION SITE HAEMORRHAGE 60 0.0008
903 ECZEMA 39 0.0007
904 BONE MARROW FAILURE 15 0.0007
905 RESTLESSNESS 27 0.0007
906 ENCEPHALOPATHY 18 0.0007
907 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 17 0.0007
908 BLOOD GLUCOSE DECREASED 35 0.0007
909 PERITONITIS 15 0.0007
910 DISTURBANCE IN ATTENTION 39 0.0007
911 SKIN EXFOLIATION 61 0.0007
912 METABOLIC ACIDOSIS 23 0.0007
913 INJECTION SITE PAIN 220 0.0007
914 CARDIAC ARREST 59 0.0007
915 INCORRECT DOSE ADMINISTERED 163 0.0007
916 PRODUCT SUBSTITUTION ISSUE 41 0.0007
917 INJECTION SITE SWELLING 54 0.0007
918 RASH GENERALISED 18 0.0007
919 ELECTROCARDIOGRAM QT PROLONGED 25 0.0007
920 BLOOD CREATINE PHOSPHOKINASE INCREASED 20 0.0007
921 MUSCLE TWITCHING 16 0.0007
922 INJECTION SITE ERYTHEMA 86 0.0007
923 PLASMA CELL MYELOMA 27 0.0007
924 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 49 0.0007
925 ANAPHYLACTIC REACTION 38 0.0007
926 DRUG EFFECT DECREASED 37 0.0007
927 THROMBOCYTOPENIA 76 0.0007
928 INJECTION SITE MASS 25 0.0007
929 NERVOUS SYSTEM DISORDER 21 0.0007
930 EYE SWELLING 25 0.0007
931 CARDIOVASCULAR DISORDER 17 0.0007
932 FEAR 18 0.0007
933 MYOCARDIAL INFARCTION 116 0.0007
934 CRYING 24 0.0007
935 MOOD ALTERED 18 0.0007
936 INJECTION SITE URTICARIA 16 0.0007
937 ABNORMAL DREAMS 18 0.0007
938 ACUTE MYOCARDIAL INFARCTION 19 0.0006
939 LEUKOPENIA 32 0.0006
940 BREAST CANCER FEMALE 17 0.0006
941 NEUTROPENIA 86 0.0006
942 DRY SKIN 84 0.0006
943 BLOOD GLUCOSE INCREASED 118 0.0006
944 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 126 0.0006
945 NEEDLE ISSUE 18 0.0006
946 EXPOSURE VIA SKIN CONTACT 16 0.0006
947 EMOTIONAL DISORDER 19 0.0006
948 RENAL FAILURE ACUTE 26 0.0006
949 ABNORMAL BEHAVIOUR 24 0.0006
950 CORONARY ARTERY DISEASE 18 0.0006
951 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 17 0.0006
952 WRONG TECHNIQUE IN DRUG USAGE PROCESS 21 0.0006
953 AGITATION 42 0.0006
954 BREAST CANCER 53 0.0006
955 LACTIC ACIDOSIS 18 0.0006
956 PRODUCT COMPLAINT 14 0.0006
957 MENTAL DISORDER 24 0.0006
958 MALIGNANT NEOPLASM PROGRESSION 56 0.0005
959 ANAPHYLACTIC SHOCK 14 0.0005
960 SEDATION 14 0.0005
961 DEVICE MALFUNCTION 37 0.0005
962 OVERDOSE 112 0.0005
963 NO ADVERSE EVENT 94 0.0005
964 INJECTION SITE RASH 15 0.0005
965 EXPIRED PRODUCT ADMINISTERED 16 0.0005
966 RHABDOMYOLYSIS 20 0.0005
967 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 16 0.0005
968 NIGHTMARE 16 0.0005
969 NEOPLASM PROGRESSION 16 0.0005
970 DEVICE ISSUE 41 0.0005
971 FOETAL EXPOSURE DURING PREGNANCY 37 0.0005
972 CONVULSION 24 0.0004
973 IRRITABILITY 25 0.0004
974 ANGER 14 0.0004
975 ACNE 31 0.0004
976 PROSTATE CANCER 32 0.0004
977 DEVICE BREAKAGE 16 0.0004
978 WITHDRAWAL SYNDROME 16 0.0004
979 SKIN IRRITATION 17 0.0004
980 VAGINAL HAEMORRHAGE 16 0.0004
981 PRODUCT STORAGE ERROR 32 0.0004
982 TOXICITY TO VARIOUS AGENTS 61 0.0004
983 DEVICE LEAKAGE 15 0.0003
984 DERMATITIS ATOPIC 18 0.0003
985 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 15 0.0003
986 ACCIDENTAL EXPOSURE TO PRODUCT 32 0.0003
987 SUICIDAL IDEATION 28 0.0003
988 DRUG DOSE OMISSION BY DEVICE 18 0.0002
989 DEVICE DIFFICULT TO USE 15 0.0002
990 SKIN BURNING SENSATION 14 0.0002
991 DRUG WITHDRAWAL SYNDROME 17 0.0002
992 DRUG DEPENDENCE 25 0.0002